Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026
Share Facebook Twitter LinkedIn Pinterest Email RH projects 10% to 13% revenue growth for fiscal 2025 with strategic product expansion
Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026